脳卒中治療に関連した分子プローブの開発と臨床応用の可能性  [in Japanese] Feasibility of molecular imaging for cerebrovascular disease and its clinical application  [in Japanese]

Access this Article

Search this Article

Author(s)

Abstract

Molecular imaging is a useful method for diagnosis of cerebral ischemic diseases as well as evaluation and monitoring of the effects of various treatments. Cu (II)-diacetyl-bis (N4-methylthiosemicarbazone) (Cu-ATSM) is a promising tracer for hypoxic imaging, which is considered to represent mitochondrial deficiency in cerebral infarction. Imaging of microglial activation using ligands for peripheral benzodiazepine receptors would be useful for evaluation of self-restoration function toward degeneration or impairment caused by cerebral infarction or other brain damages. Molecular imaging technique with PET would be able to utilize for monitoring and follow-up of various treatments such as gene therapy and transplantation.<br>

Journal

  • Nosotchu

    Nosotchu 30(6), 817-821, 2008-11-25

    The Japan Stroke Society

Codes

  • NII Article ID (NAID)
    10024937209
  • NII NACSIS-CAT ID (NCID)
    AN0020186X
  • Text Lang
    JPN
  • Article Type
    REV
  • ISSN
    09120726
  • Data Source
    CJP  J-STAGE 
Page Top